MYIIX
Price
$7.57
Change
+$0.03 (+0.40%)
Updated
Jan 14 closing price
Net Assets
205.48M
VTPSX
Price
$125.39
Change
+$0.92 (+0.74%)
Updated
Jan 14 closing price
Net Assets
431.86B
Ad is loading...

MYIIX vs VTPSX

Header iconMYIIX vs VTPSX Comparison
Open Charts MYIIX vs VTPSXBanner chart's image
NYLI WMC International Research Eq Cl I
Price$7.57
Change+$0.03 (+0.40%)
VolumeN/A
Net Assets205.48M
Vanguard Total Intl Stock Idx InstlPls
Price$125.39
Change+$0.92 (+0.74%)
VolumeN/A
Net Assets431.86B
MYIIX vs VTPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MYIIX vs. VTPSX commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYIIX is a Buy and VTPSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTPSX has more cash in the bank: 432B vs. MYIIX (205M). VTPSX pays higher dividends than MYIIX: VTPSX (3.30) vs MYIIX (1.96). MYIIX was incepted earlier than VTPSX: MYIIX (17 years) vs VTPSX (14 years). MYIIX has a lower initial minimum investment than VTPSX: MYIIX (1000000) vs VTPSX (100000000). MYIIX annual gain was more profitable for investors over the last year : 7.34 vs. VTPSX (2.75). MYIIX return over 5 years is better than : 10.53 vs. VTPSX (7.84).
MYIIXVTPSXMYIIX / VTPSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD-1.304-1.073122%
Front LoadN/AN/A-
Min. Initial Investment10000001000000001%
Min. Initial Investment IRAN/AN/A-
Net Assets205M432B0%
Annual Yield % from dividends1.963.3059%
Returns for 1 year7.342.75267%
Returns for 3 years1.08-6.48-17%
Returns for 5 years10.537.84134%
Returns for 10 years12.9231.0342%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARE17.030.64
+3.90%
Carter Bankshares
ESGR326.500.43
+0.13%
Enstar Group Limited
HSY155.31-1.97
-1.25%
Hershey Company (The)
ANTX1.22-0.04
-3.17%
AN2 Therapeutics
EVEX4.20-0.15
-3.45%
Eve Holding